Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus

Use of zinc and copper gluconate in the treatment of methicillin-resistant Staphylococcus aureus

US Patent 10645953 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral use of zinc and copper gluconates in the treatment of digital dermatitis2019
Can2007